SCHEMBL4500210

SCHEMBL4500210

C1=CN=Nc2ccccc2C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4500203 1.00
SCHEMBL18321041 0.98
SCHEMBL18321043 0.98
SCHEMBL211354 0.77 TRPA1 (0.30)
SCHEMBL6843536 0.73 MAPT (0.39)
SCHEMBL2494939 0.72 CDC25B (0.41)
SCHEMBL8655845 0.70
SCHEMBL8655839 0.70
SCHEMBL184014 0.69
SCHEMBL160697 0.68 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1144369-B1 ACETYLENIC ARYL SULFONAMIDE AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS WYETH CORP (US) 2004-07-21 EP claimed
US-6762178-B2 FOR USE IN TREATMENT OF DISEASE CONDITIONS MEDIATED BY TNF-ALPHA, SUCH AS RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, SEPSIS, AIDS, ULCERATIVE COLITIS, MULTIPLE SCLEROSIS, CROHN'S DISEASE, DEGENERATIVE CARTILAGE LOSS WYETH HOLDINGS CORPORATION 2004-07-13 US claimed
CN-1376144-A Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors AMERICAN CYANAMID CO (US) 2002-10-23 CN claimed
US-20010056088-A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors AMERICAN CYANAMID COMPANY (US) 2001-12-27 US claimed
EP-1144369-A2 ACETYLENIC ARYL SULFONAMIDE AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS American Cyanamid Company (US) 2001-10-17 EP claimed
WO-2000044710-A2 ACETYLENIC ARYL SULFONAMIDE AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-08-03 WO claimed
US-4595531-A Thermal treatment of benzodiazocine in an inert solvent in the presence of a nucleophilic agent or with a halogenating Lewis acid KALI-CHEMIE AG (DE) 1986-06-17 US claimed
US-4243585-A Bendodiazocine derivatives and process of making the same KALI-CHEMIE AKTIENGESELLSCHAFT (DE) 1981-01-06 US claimed
CN-117820333-A KRAS G12C inhibitors 伊莱利利公司 2024-04-05 CN disclosed
US-11535627-B2 Pyrimidine derivative compound, pharmaceutically acceptable salt thereof, preparation process thereof, and pharmaceutical composition using the same SPARK BIOPHARMA, INC. (KR) 2022-12-27 US disclosed
CN-114728000-A Novel pharmaceutical combination for the treatment of cancer 荷兰癌症研究所-安东尼·范·雷文虎克医院基金会 2022-07-08 CN disclosed
CN-114514032-A Angiotensin type 2 (AT2) receptor agonists for the treatment of cancer 兰提欧派普有限公司 2022-05-17 CN disclosed
CN-108430515-B Antibody conjugates comprising TOLL-like receptor agonists 诺华股份有限公司 2021-11-12 CN disclosed
EP-3524608-B1 NOVEL PYRIMIDINE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION USING SAME SPARK BIOPHARMA INC (KR) 2020-12-30 EP disclosed
US-4017312-A Method of manufacturing an article carrying a relief image receptor material comprising exposure and heating steps MITSUBISHI PLASTICS INDUSTRIES, LIMITED (JA) 1977-04-12 US disclosed
US-4001233-A CNS STIMULANTS, MUSCLE RELAXANTS E. R. SQUIBB & SONS, INC. (US) 1977-01-04 US disclosed
US-3998809-A ANTICONVULSANTS, SEDATIVES, MUSCLE RELAXANTS, TRANQUILIZERS KALI-CHEMIE AKTIENGESELLSCHAFT (DT) 1976-12-21 US disclosed
US-3994920-A APPETITE SUPPRESSANT, ANTIDEPRESSANT AMERICAN HOME PRODUCTS CORPORATION (US) 1976-11-30 US disclosed
US-3978058-A SEDATIVE, ANTIINFLAMMATORY, ANTICONVULSANT, DIURETIC TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1976-08-31 US disclosed
US-3957787-A CENTRAL NERVOUS SYSTEM STIMULANTS, MUSCLE RELAXANTS E. R. SQUIBB & SONS, INC. (US) 1976-05-18 US disclosed